We have some exciting news to share! The Motley Fool UK has now become The Twelfth Magpie -- an independent, UK-owned company, led by our long-serving UK management team — Mark Rogers, Chris Nials and Heather Adlington. In practical terms, it’s the same team you know, now fully focused on serving our UK readers and members.

Just as importantly, our approach remains unchanged: long-term, jargon-free, and on your side. This site is our new home, and there will be extra tweaks made across the coming few days as we settle in. So if anything looks a little off, please bear with us!

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

GlaxoSmithKline plc and Royal Dutch Shell plc: 2 income champions to protect you from Brexit risks

GlaxoSmithKline plc (LON: GSK) and Royal Dutch Shell Plc (LON: RDSB) are two companies that could be immune to Brexit risks.

You’re reading a free article with opinions that may differ from The Twelfth Magpie’s Premium Investing Services. Become a member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn more, and get a free 'Best Buy Now' stock!.

There’s one concern dominating the minds of investors at the moment and that’s Brexit. Indeed, if Britain votes to leave the EU on 23 June, the country will be subject to a multi-year period of uncertainty, and it’s this uncertainty that will cause investors the most pain.

To protect against uncertainty and any adverse effects that may come as a result of Britain’s decision to leave the EU, investors could look to large international firms with well-covered dividend yields and well-positioned to succeed in any economic environment.

Should you buy Rolls Royce shares today?

Before you decide, please take a moment to review this report first. Despite ongoing uncertainties from US tariffs to global conflicts, Mark Rogers and his team believe many UK shares still trade at substantial discounts, offering savvy investors plenty of potential opportunities to learn about.

That’s why this could be an ideal time to secure this valuable research – Mark’s analysts have scoured the markets to reveal 5 of his favourite long-term ‘Buys’. Please, don’t make any big decisions before seeing them.

Defensive business 

GlaxoSmithKline (LSE: GSK) is one such company. The pharmaceuticals giant is a world leader in the production of consumer pharmaceutical products, such as over-the-counter medicines, toothpaste and painkillers. What’s more, the group has a large vaccines division as well as a stake in ViiV Healthcare, a joint venture dedicated to delivering advances in treatment and care for people living with HIV. It’s extremely unlikely that any one of these businesses will see a sudden drop-off in demand for their products in the event of a Brexit.

Moreover, this year Glaxo is on track to report its first year of earnings growth since 2011, so there’s already a significant amount of positive sentiment surrounding the group. City analysts expect the company to report earnings growth of 16% this year, followed by growth of 5% for 2017.

Management has already come out to confirm it’s on track to meet this target. In fact, the first quarter of 2016 was one of the most impressive in several years for the company. Sales increased by 11%, to £6.2bn and earnings per share, excluding exceptional items and adjusted for currency, rose 8% to 19.8p. Shares in Glaxo currently trade at a forward P/E of 15.9 and support a dividend yield of 5.7%.

Global oil company 

Royal Dutch Shell (LSE: RDSB) is another large international company that’s unlikely to be significantly affected by a leave vote. As one of the largest oil traders in Europe and one of the biggest integrated oil companies in the world, Shell is a vital part of the global economy. 

This means that the group is likely to continue to churn out returns for investors no matter what the future holds for the UK economy.

Over the next few years, Shell’s earnings should climb steadily higher as the company continues its integration of recently acquired BG Group and cuts costs further to deal with the slump in oil prices. Asset sales should bolster the enlarged group’s balance sheet while improving margins as low-return assets are sold off.

Shares in Shell currently trade at a forward P/E of 23.7 and support a dividend yield of 7.2%. Management has announced its commitment to the dividend for the foreseeable future so a payout should be secure no matter what the outcome on 23 June.

Rupert Hargreaves owns shares of GlaxoSmithKline and Royal Dutch Shell B. The Motley Fool UK owns shares of and has recommended GlaxoSmithKline. The Motley Fool UK has recommended Royal Dutch Shell B. We Fools don't all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Close-up image depicting a woman in her 70s taking British bank notes from her colourful leather wallet.
Growth Shares

Turning a £20k ISA into a £12,508 second income

Reinvesting dividends at high yields is one way to earn a second income. But long-term investors should also check out…

Read more »

Black woman using smartphone at home, watching stock charts.
Investing Articles

The Nvidia share price still hasn’t recovered post-earnings. Should I be worried?

Jon Smith explains why the Nvidia share price has traded lower over the past couple of weeks, and offers his…

Read more »

Thoughtful man using his phone while riding on a train and looking through the window
Investing Articles

Just Released: Our Top Value Stock For ISAs In June 2026 [PREMIUM PICKS]

We've just named our top value stock for June 2026 with 31 years of dividend growth under its belt, still…

Read more »

Man hanging in the balance over a log at seaside in Scotland
Investing Articles

The market just sold this FTSE 100 stock. I think it’s focusing on the wrong risk

Andrew Mackie examines whether a recent sell-off has created an opportunity in a FTSE 100 miner for investors worried about…

Read more »

Hand is turning a dice and changes the direction of an arrow symbolizing that the value of an ETF (Exchange Traded Fund) is going up (or vice versa)
Investing Articles

3 top ETFs to consider for a Stocks and Shares ISA in June

A couple of well-chosen ETFs can really boost an ISA portfolio's performance. Here, our writer names a trio that are…

Read more »

Woman riding her old fashioned bicycle along the Beach Esplanade at Aberdeen, Scotland.
Investing Articles

How to invest £20k in 3 FTSE 100 stocks to get a stunning 7% dividend yield

Harvey Jones picks out some FTSE 100 income stocks that together could deliver a combined yield of more than 7%,…

Read more »

Night Takeoff Of The American Space Shuttle
Investing Articles

Tempted by SpaceX? Is it worth considering Scottish Mortgage shares instead?

Ahead of the SpaceX IPO, James Beard discusses whether it’s time to consider an alternative strategy by taking a stake…

Read more »

A rear view of a female in a bright yellow coat walking along the historic street known as The Shambles in York, UK which is a popular tourist destination in this Yorkshire city.
Investing Articles

Will we see a catastrophic stock market crash this year?

The stock market's near record highs, but one overlooked FTSE 100 giant's still trading well below its peak and analysts…

Read more »